Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK.

The Journal of hospital infection·2024
Same author

Recommendations on the use of azole antifungals in hematology-oncology patients.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2023
Same author

Latent tuberculosis infection: approach and therapeutic schemes.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022
Same author

Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.

Open forum infectious diseases·2022
Same author

Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022
Same author

Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.

Open forum infectious diseases·2021

Related Experiment Video

Updated: Feb 23, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

5.9K

Invasive candidiasis in the neutropenic patient.

J Fortún1, F Gioia

  • 1Jesús Fortún, Infectious Diseases Service, Hospital Ramón y Cajal, Madrid, Spain. fortunabete@gmail.com.

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|September 9, 2017
PubMed
Summary

Invasive candidiasis in neutropenic patients has a 30% mortality rate, similar to the general population. Echinocandins are recommended as first-line therapy due to their safety profile.

More Related Videos

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

2.2K
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.5K

Related Experiment Videos

Last Updated: Feb 23, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

5.9K
Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

2.2K
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.5K

Area of Science:

  • Infectious Diseases
  • Hematology
  • Critical Care Medicine

Background:

  • Invasive candidiasis and candidemia present distinct epidemiological and prognostic profiles in neutropenic patients.
  • Despite differences, a recent Spanish study (Candipop) reported a 1-month mortality rate of 30% in neutropenic patients, comparable to the general population.

Purpose of the Study:

  • To analyze the epidemiology and outcomes of invasive candidiasis in neutropenic patients.
  • To evaluate treatment strategies and species prevalence in this patient group.

Main Methods:

  • A study conducted in Spanish hospitals (Candipop) analyzed data on invasive candidiasis in neutropenic patients.
  • The study identified common Candida species and assessed treatment outcomes.

Main Results:

  • Candida albicans remains the most frequent isolate, but non-albicans Candida species (e.g., C. tropicalis, C. glabrata, C. krusei) are more prevalent in neutropenic patients compared to non-neutropenic individuals.
  • Neutrophil transfusion efficacy remains uncertain, and decisions regarding catheter removal should be individualized and diagnosis-confirmed.
  • Echinocandins emerged as the preferred first-line treatment, demonstrating a superior safety profile.

Conclusions:

  • Invasive candidiasis in neutropenic patients carries a significant mortality risk, necessitating optimized therapeutic approaches.
  • The prevalence of specific Candida species highlights the importance of species identification for targeted therapy.
  • Echinocandins represent a safe and effective first-line treatment option for invasive candidiasis in neutropenic patients.